No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 12, 2004, Pages 2280-2281

  Li, Li ^a   Cicek, Mine S ^b   Casey, Graham ^b   Witte, John S ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYTOCHROME P450; NUCLEOTIDE;

ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AROMATASE; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PEDIGREE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; SIBLINGS;

EID: 11144244403     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Vogt K, Bartsch W. Intratissular androgens in benign prostatic hyperplasia and prostatic cancer. J Steroid Biochem Mol Biol 1986;25:749-57.
2. Hiramatsu M, Maehara I, Ozaki M, Harada N, Orikasa S, Sasano H. Aromatase in hyperplasia and carcinoma of the human prostate. Prostate 1997;31:118-24.
3. Yeh S, Miyamoto H, Shrima H, Chang C. From estrogen to androgen receptor: a new pathway for sex hormone in prostate. Proc Natl Acad Sci U S A 1998;95:5527-32.
4. Farnsworth WE. Roles of estrogen and SHBE in prostate physiology. Prostate 1996;28:17-23.
5. Latil AG, Azzouzi R, Cancel GS, et al. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer 2001;92:1130-7.
6. Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS. CYP3A4 and CYP3A5 genotypes, haplotypes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2003;12:928-32.